Caffeic Acid 3-O-Methyltransferase Selective Vanillin Biosynthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing vanilloid compounds in recombinant yeast hosts are not sufficiently selective for vanillin, leading to the production of undesirable by-products like isovanillin, resulting in low vanillin/isovanillin ratios and impurities that hinder industrialization.
Innovation Solution
A method involving a recombinant yeast host expressing a caffeic acid 3-O-methyltransferase polypeptide with at least 80% sequence identity to specific plant-derived enzymes, which selectively methylates protocatechuic aldehyde to produce substantially pure vanillin, by excluding enzymes like phenylalanine ammonia lyase and crotonase, and cultivating the host in a suitable medium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional O-methyltransferases are used for vanillin production, then the biosynthesis pathway can be established, but the selectivity is poor leading to high levels of isovanillin by-products
Solution Approach 1:
The patent changes the enzymatic parameter by replacing conventional catechol O-methyltransferase with caffeic acid 3-O-methyltransferase, which has different substrate specificity and methylation position preference, thereby producing vanillin selectively without isovanillin by-products
Solution Approach 2:
The patent extracts and eliminates the harmful by-product formation mechanism by removing the enzymatic activity that produces isovanillin, achieving complete selectivity for vanillin production
2Quantity of substance
If metabolic engineering pathways are introduced into yeast, then vanillin production capability is achieved, but product purity remains low due to impurities
Solution Approach 1:
The patent changes the enzymatic parameter by introducing caffeic acid 3-O-methyltransferase with specific substrate preference for protocatechuic aldehyde, which directs the metabolic flux toward vanillin production with high purity and eliminates impurities
3Adaptability or versatility
If recombinant yeast strains are used for bioconversion, then natural product synthesis is achieved, but the vanillin/isovanillin ratio is insufficient for industrialization
Solution Approach 1:
The patent changes the enzymatic parameter by using caffeic acid 3-O-methyltransferase instead of conventional O-methyltransferases, which fundamentally alters the methylation specificity and achieves vanillin/isovanillin ratio exceeding 125:1
Solution Approach 2:
The patent converts the potential harm of by-product formation into benefit by designing a metabolic pathway where the enzyme substrate specificity inherently prevents by-product formation, making the process completely selective for the desired product
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves high selectivity for vanillin production, exceeding a vanillin/isovanillin molar ratio of 125:1, resulting in a vanillin product with over 99.2% purity, effectively reducing impurities and improving the industrial viability of vanillin biosynthesis.
Implementation Method 1
expressing a caffeic acid 3-O-methyltransferase polypeptide... which selectively methylates protocatechuic aldehyde to produce substantially pure vanillin
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
The present invention relates to methods for producing vanilloid compounds in a recombinant host, and in particular for converting a protocatechuic aldehyde into a substantially pure vanilloid. It further relates to novel yeast strains that are suitable for producing such vanilloid compounds.